Advance Research Associates Selects OmniComm System's TrialMaster(R) EDC Solution to Standardize Data Management

OmniComm Systems, Inc. , one of the fastest growing companies in the EDC marketplace announced today that it has entered into a strategic partnership with Advance Research Associates www.araonline.net)">, a Contract Research Organization (CRO) located in Mountain View, CA.

TrialMaster®, the core product of OmniComm www.omnicomm.com)">, provides Advance Research Associates (ARA) and other trial sponsors with a 21 CRF Part 11 compliant Web-based data and trial management solution that greatly increases the efficiency, security and integrity of clinical research data. Founded in 1996, ARA has become a trusted clinical research partner to the pharmaceutical, biotech, and medical device industries. In the years since its inception, ARA has provided a spectrum of innovative solutions and lent its expertise across a wide range of projects.

"While we provide services similar to other Contract Research Organizations, we pride ourselves in the quality of the services we provide, in our attentiveness to each client's individual needs and in our focus on working with our clients in accomplishing their clinical program goals," stated ARA's President, Peter Shabe. Shabe added, "Sponsors are routinely asking us about EDC. They are seeking ways to reduce development time while giving them better data faster in order to drive crucial decisions. OmniComm offers a flexible and easy to navigate trial and data capture solution and a technology infrastructure that is scalable and cost effective."

OmniComm System's CEO, Cornelis Wit, stated, "TrialMaster has been recognized by pharmaceutical, biotech and medical device companies as the ideal EDC solution due to its combination of flexibility, ease of use, and affordability. The collaboration between OmniComm and ARA will help our collective clients successfully transition to EDC and realize their objective of better data, faster."

About Advance Research Associates

Founded in 1996, Advance Research Associates has become a trusted clinical research partner to the pharmaceutical, biotech, and medical device industries. In the years since its inception, ARA has provided a spectrum of innovative solutions and lent its expertise across a wide range of projects. While these customized solutions are always based entirely on client need, the success of any project hinges on the strength of the personal relationship developed between client and partner through daily communication. ARA's collaborative management philosophy supports extensive interaction, resulting in clients consistently achieving their highest objectives. With more than 75 years of collective practical clinical research experience, the seasoned ARA staff has the right skills to successfully manage your next clinical research program.

About OmniComm Systems, Inc.

OmniComm Systems, Inc. is one of the fastest growing companies in the EDC market place targeting its product TrialMaster to the pharmaceutical, medical device and biotechnology companies as well as CRO's. TrialMaster is currently being deployed on global trials sponsored by several top tier biopharmaceutical companies. OmniComm's growing base of satisfied customers is a direct result of OmniComm's employee's commitment to on-time, quality and with-in budget performance. The TrialMaster www.trialmaster.com)"> system, the core product of OmniComm, provides trial sponsors with a 21 CRF Part 11 compliant Internet-based data and trial management solution that greatly increases the efficiency, security and integrity of clinical research data and thus significantly reduces the time and expense involved in conducting clinical studies.

Safe Harbor Disclaimer

Statements about OmniComm's future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm's operations, markets and profitability, actual results could differ materially and adversely from the expected results.

---

Distributed by Market Wire